Advertisement
Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

The prevalence of Cryptosporidium, and identification of the Cryptosporidium horse genotype in foals in New York State.

13:46 EDT 24th July 2014 | BioPortfolio

Summary of "The prevalence of Cryptosporidium, and identification of the Cryptosporidium horse genotype in foals in New York State."

To date, little is known about the prevalence, genotypes and zoonotic potential of Cryptosporidium spp. affecting horses, especially in North America. A cross-sectional study was conducted in New York, USA between February 25th and May 1st 2009. Fecal samples were collected from three hundred and forty nine 1-10-week-old foals and their dams on 14 different broodmare farms. All fecal samples were screened for Cryptosporidium spp. using a direct immunofluorescence assay (DFA). DNA extraction and PCR-RFLP analysis of the small-subunit (SSU) rRNA gene were performed on all the foal samples. PCR-positive samples were subtyped by DNA sequencing of the 60-kDa glycoprotein (gp60) gene. On DFA, 13/175 (7.4%) foal samples and 3/174 (1.7%) mare samples were designated positive for Cryptosporidium spp., whereas on SSU rRNA-based PCR, 9/175 (5.1%) foal samples were positive. Cryptosporidium PCR-positive foals were significantly older (13-40 days, median age of 28 days) compared with negative foals (4-67 days, median 18 days, p=0.02). The number of foals with diarrhea or soft feces was not significantly different between positive and negative foals (p=0.09). PCR-RFLP analysis of the SSU rRNA gene and DNA sequencing of the gp60 gene identified the parasite as subtype VIaA14G2 of the horse genotype. This is the first report of a group of foals affected with the Cryptosporidium horse genotype, which has recently been detected in humans. As other contemporary molecular studies have identified C. parvum in foals, it seems that equine cryptosporidiosis should be considered a zoonosis.

Affiliation

Department of Population Medicine and Diagnostic Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853, USA. ab446@uga.edu

Journal Details

This article was published in the following journal.

Name: Veterinary parasitology
ISSN: 1873-2550
Pages: 139-44

Links

PubMed Articles [11759 Associated PubMed Articles listed on BioPortfolio]

High occurrence of Cryptosporidium ubiquitum and Giardia duodenalis genotype E in sheep from Brazil.

In this paper we report the occurrence of zoonotic species of Cryptosporidium (C. ubiquitum and C. parvum subtype IIaA15G2R1) and the host-specific Giardia duodenalis genotype E in a sheep farm from B...

Prevalence of Cryptosporidium Infection in Sheep in Iran.

Objective: Cryptosporidium is an important zoonotic parasite in humans and animals worldwide. This study was conducted to investigate the prevalence of Cryptosporidium infection in Iran. Methods: Feca...

Identification of Cryptosporidium subtype isolates from HIV-seropositive patients in Equatorial Guinea.

Cryptosporidium spp. are enteric parasites that infect humans and animals. In immunocompromised patients infection can be fatal. This study was conducted to identify sub-populations of Cryptosporidium...

Factors influencing on prevalence of Cryptosporidium infection in south Indian dairy calves.

The objectives of the present study were to report the influence of factors like age, sex, breed, dung consistency and rearing system on prevalence of Cryptosporidium spp. in south Indian cattle. Two-...

Occurrence and molecular characterization of Cryptosporidium in dogs in Henan Province, China.

Cryptosporidiosis in dogs has been reported worldwide, involving both asymptomatic and diarrheic dogs. Large-scale surveys of Cryptosporidium infection in dogs have been performed in some countries us...

Clinical Trials [1254 Associated Clinical Trials listed on BioPortfolio]

A Randomized, Multicenter, Double-Blind, Parallel-Group, Placebo-Controlled Trial of the Efficacy and Safety of Bovine Anti-Cryptosporidium Immunoglobulin (BACI) in the Treatment of Cryptosporidium Enteritis in AIDS Patients

PRIMARY: To assess the effect of bovine anti-Cryptosporidium immunoglobulin (BACI) on the volume of diarrhea due to Cryptosporidium parvum in AIDS patients who have protracted Cryptosporid...

A Study to Evaluate the Use of Nitazoxanide to Treat Cryptosporidiosis

The purpose of this study is to see if nitazoxanide (NTZ) can be used to treat AIDS patients suffering from cryptosporidiosis (diarrhea caused by the parasite Cryptosporidium).

Open-Label "Compassionate" Use Study of Spiramycin for the Treatment of Diarrhea Due to Chronic Cryptosporidiosis in Immunocompromised Patients

This protocol provides for the availability of spiramycin under compassionate-use conditions for the treatment of chronic diarrhea due to cryptosporidium in patients with a compromised imm...

The Effectiveness of Cow's Milk Immune Globulin in the Treatment of AIDS-Related Diarrhea

To examine the efficacy of cow's milk immune globulin in the treatment of diarrhea due to chronic intestinal cryptosporidiosis in patients with AIDS. The secondary end points of the study...

Horse Chestnut Seed Extract for Lymphedema

The objectives of this study are to evaluate the effectiveness of escin (as horse chestnut seed extract) for arm lymphedema in women following treatment for breast cancer, to evaluate the...

Medical and Biotech [MESH] Definitions

A family of parasitic organisms in the order EIMERIIDA. CRYPTOSPORIDIUM is the most important genus.

A genus of coccidian parasites of the family CRYPTOSPORIDIIDAE, found in the intestinal epithelium of many vertebrates including humans.

Intestinal infection with organisms of the genus CRYPTOSPORIDIUM. It occurs in both animals and humans. Symptoms include severe DIARRHEA.

A species of parasitic protozoa that infects humans and most domestic mammals. Its oocysts measure five microns in diameter. These organisms exhibit alternating cycles of sexual and asexual reproduction.

Search BioPortfolio: